%0 Journal Article
%T Primary Bladder Adenocarcinoma: A Five-Year Retrospective Clinicopathologic Study of 42 Cases in Egyptian NCI (2010-14)
%A Yahia Ismail
%A Amr Kamal
%A Osama Yousof
%A Neveen Tahoun
%A Rasha Allam
%J Journal of Cancer Therapy
%P 97-116
%@ 2151-1942
%D 2019
%I Scientific Research Publishing
%R 10.4236/jct.2019.101008
%X <strong><u><em>Aim</em></u></strong><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">: Globally, primary adenocarcinoma</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">(AC) accounts for only 0.5% - 2% of bladder cancer</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">(BC). Bilharziasis predisposes to AC in ~10% of BC
in endemic regions. The aim was to study the clinicopathologic characteristics
of this rare entity and define prognostic elements influencing disease-free</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">(DFS) &amp; overall survival</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"> </span></span></span><span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">(OS). </span><b><i><u><span style=\"font-family:Verdana;\">Patients</span></u></i><u><span> <i><span style=\"font-family:Verdana;\">&amp;</span></i> <i><span style=\"font-family:Verdana;\">Methods</span></i></span></u></b><span style=\"font-family:Verdana;\">:
A retrospective analysis of 42 cases of primary bladder AC presented to the
National Cancer Institute of Egypt (NCI-E) during a five-year period (2010-2014),
clinicopathologic profiles, management and survival were assessed. </span><b><i><u><span style=\"font-family:Verdana;\">Results</span></u></i><u><span style=\"font-family:Verdana;\">: </span></u></b><span style=\"font-family:Verdana;\">The mean age was 55.5 years
¡À</span></span></span></span><span><span><span style=\"font-family:;\" \"=\"\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">9.77 with male predominance. Hematuria, bilharziasis
&amp; urachal type experienced in 88%, 35.7% &amp; 4.8%,</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">respectively. Radical surgery was employed in 64.3%.
Metastatic disease (stageIVB) found in 14.3%,
%K Bladder Cancer
%K Primary
%K Adenocarcinoma
%K Bilharziasis
%K NCI
%K Egypt
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=90132